DRKS00032128
Not Yet Recruiting
N/A
A non-interventional, prospective study to evaluate change in physical activity, relationship satisfaction and psychological well-being in patients with rheumatoid arthritis after introduction of the JAK inhibitor filgotinib and also in their partners. - Effect of JAK inhibition in RA on quality of life and partnership.
Helios Fachklinik Vogelsang-Gommern, Rheumatologie0 sites40 target enrollmentJune 26, 2023
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- M06.8
- Sponsor
- Helios Fachklinik Vogelsang-Gommern, Rheumatologie
- Enrollment
- 40
- Status
- Not Yet Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Experimental group: Filgotinib naive R.A.,
- •The patient is able to understand and give written, voluntary consent.
- •Diagnosis of active RA and prescription of a new Filgotinib therapy by the treating rheumatologist.
- •Partners: no rheumatic diseases, no treatment with DMARDs
Exclusion Criteria
- •Patient participates concurrently in another clinical trial.
- •Known relevant heart, lung diseases or other medical contraindications that could influence the examination results.
- •Patient is not able to participate due to any medical or psychological condition according to physician\`s decision.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, Not Recruiting
N/A
A prospective non-interventional study to evaluate the effect of Triptorelin Embonate (Diphereline (Trademark TM) 11.25mg) on lower urinary tract symptoms (LUTS) in Australian prostate cancer patients.ocally advanced or metastatic prostate cancer with Lower Urinary Tract Symptoms (LUTS)Locally advanced or metastatic prostate cancer with Lower Urinary Tract Symptoms (LUTS)Cancer - ProstateRenal and Urogenital - Other renal and urogenital disordersACTRN12610000558022Ipsen Pty Ltd70
Completed
N/A
A prospective, non-interventional study to investigate the effectiveness of a recombinant fusion protein linking coagulation Factor IX with recombinant albumin (rIX-FP) in patients with hemophilia BD67Hereditary factor IX deficiencyDRKS00015079CSL Behring GmbH73
Completed
N/A
A retrospective non-interventional study evaluating retention rate of Everolimus as add-on epilepsy therapy in adult patients with tuberose sclerosisQ85.1Tuberous sclerosisDRKS00020248Epilepsiezentrum Kork45
Completed
N/A
A prospective non-interventional study to assess quality of life and COPDsymptoms in patients with COPD on LAMA/LABA/ICS triple therapy withElebrato® Ellipta®J44.9Chronic obstructive pulmonary disease, unspecifiedDRKS00031897BERLIN-CHEMIE AG931
Recruiting
Phase 4
Performance and safety evaluation of pelvic plate system fixation during fractures, fusions, andosteotomies of the acetabulum, sacrum, ilium, and entire pelvic ring, as well as treatment of sacroiliac jointHealth Condition 1: S329- Fracture of unspecified parts of lumbosacral spine and pelvisCTRI/2023/06/053602Auxein Medical Pvt. Ltd